The commercial failure of Biogen Inc.’s drug Aduhelm is putting new focus on the state of research into the causes of Alzheimer’s disease.

More than six million people in the U.S. are living with the progressive type of dementia, according to the Alzheimer’s Association, an advocacy group.

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Ready to turn in your car lease? Record-high prices could mean a financial bonanza.

For savvy motorists who’ve been leasing a vehicle they’re now ready to…

Suicide attack by Pakistan’s Taliban kills at least 4, injures 20

PESHAWAR, Pakistan — A suicide attack left at least 4 dead and…

Seattle officer who said dead Indian woman had ‘limited value’ will face discipline, department says

SEATTLE (AP) — A Seattle police officer violated policing standards when he…

An American citizen was killed in Iranian attack in Iraq, State Department says

An American citizen was killed in an Iranian missile and drone attack…